Beam Therapeutics reported promising Phase 1/2 data for BEAM-302, demonstrating durable gene correction for AATD. See why I ...

Glaucoma Research Foundation (GRF) announced the nine recipients of its $55,000 one-year Shaffer Research Grants. "We are extremely fortunate for the ongoing and generous investment from our glaucoma ...

EMERYVILLE, Calif., March 17, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company ...

Cystic fibrosis (CF) is a life-threatening autosomal recessive disease affecting over 160,000 people worldwide. CF is caused by loss-of-function mutations in the CF transmembrane conductance regulator ...

H.C. Wainwright analyst Patrick Trucchio reiterates a Buy rating and $80 price target on Beam Therapeutics (BEAM) shares after the company ...

He's term limited as governor after 2026. So why not start a pod and start having guests who might attract an audience outside your own political base. And certainly, Charlie Kirk, at age 31, with ...

Chase Fralick got it.” Leading 7-4 with two outs and the bases loaded in the seventh inning, Fralick hit a backside double to clear the bases and push Auburn’s lead to six. The game marked ...

The authors have demonstrated the use of adenine base editors delivered via adeno-associated viruses to introduce edits in the mitochondrial genome. The manuscript describes the methodology well, and ...

Iran’s floating bases can attack targets with mixed strike packages consisting of naval drones, loitering munitions and aerial drones, anti-ship ballistic missiles, anti-ship cruise missiles, and ...

The Base, formed in 2018, proscribed as a terrorist organization in several countries, appears to be undergoing a resurgence which experts attribute to seizing a “window of opportunity” with ...